Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Albemarle Corporation stock logo
ALB
Albemarle
$79.62
-6.2%
$74.29
$49.43
$113.91
$9.37B1.643.55 million shs4.04 million shs
Chubb Limited stock logo
CB
Chubb
$276.52
+0.5%
$275.50
$252.16
$306.91
$110.25B0.561.79 million shs1.70 million shs
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$243.75
-1.3%
$235.45
$187.43
$352.33
$17.53B1.05831,267 shs405,572 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Albemarle Corporation stock logo
ALB
Albemarle
0.00%+4.39%+24.91%+48.80%-5.96%
Chubb Limited stock logo
CB
Chubb
0.00%+0.21%+2.89%-7.27%-3.19%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.00%+0.08%+3.36%+17.25%-21.19%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Albemarle Corporation stock logo
ALB
Albemarle
3.0292 of 5 stars
2.02.02.50.63.51.70.6
Chubb Limited stock logo
CB
Chubb
4.7214 of 5 stars
2.23.04.22.02.43.33.1
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
4.8728 of 5 stars
3.43.01.73.23.71.73.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Albemarle Corporation stock logo
ALB
Albemarle
1.94
Reduce$86.478.61% Upside
Chubb Limited stock logo
CB
Chubb
2.33
Hold$302.009.21% Upside
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
2.89
Moderate Buy$320.7131.57% Upside

Current Analyst Ratings Breakdown

Latest ALB, WST, and CB Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/29/2025
Albemarle Corporation stock logo
ALB
Albemarle
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetUnderperform ➝ Underperform$58.00 ➝ $68.00
8/26/2025
Albemarle Corporation stock logo
ALB
Albemarle
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSell ➝ Neutral$62.00 ➝ $89.00
8/18/2025
Albemarle Corporation stock logo
ALB
Albemarle
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$60.00 ➝ $80.00
8/18/2025
Chubb Limited stock logo
CB
Chubb
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$300.00 ➝ $295.00
8/13/2025
Chubb Limited stock logo
CB
Chubb
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
8/13/2025
Chubb Limited stock logo
CB
Chubb
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$326.00
8/12/2025
Chubb Limited stock logo
CB
Chubb
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$290.00
8/4/2025
Albemarle Corporation stock logo
ALB
Albemarle
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetHold ➝ Hold$74.00
8/1/2025
Albemarle Corporation stock logo
ALB
Albemarle
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Perform ➝ Sector Perform$65.00 ➝ $70.00
8/1/2025
Albemarle Corporation stock logo
ALB
Albemarle
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$75.00 ➝ $70.00
8/1/2025
Chubb Limited stock logo
CB
Chubb
Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
(Data available from 9/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Albemarle Corporation stock logo
ALB
Albemarle
$5.38B1.74$3.59 per share22.18$67.76 per share1.17
Chubb Limited stock logo
CB
Chubb
$55.75B1.98$22.83 per share12.11$169.67 per share1.63
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$2.89B6.06$8.89 per share27.41$37.04 per share6.58
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Albemarle Corporation stock logo
ALB
Albemarle
-$1.18B-$9.32N/A41.68N/A-18.61%-1.87%-0.89%11/5/2025 (Estimated)
Chubb Limited stock logo
CB
Chubb
$9.27B$22.6712.2011.003.1016.08%12.34%3.47%11/4/2025 (Estimated)
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$492.70M$6.6836.4931.014.3816.48%18.43%13.67%10/23/2025 (Estimated)

Latest ALB, WST, and CB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2025Q2 2025
Albemarle Corporation stock logo
ALB
Albemarle
-$0.83$0.11+$0.94-$0.16$1.23 billion$1.33 billion
7/24/2025Q2 2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$1.51$1.84+$0.33$1.82$725.11 million$766.50 million
7/22/2025Q2 2025
Chubb Limited stock logo
CB
Chubb
$5.84$6.14+$0.30$7.35$12.53 billion$14.20 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Albemarle Corporation stock logo
ALB
Albemarle
$1.622.03%N/AN/A 30 Years
Chubb Limited stock logo
CB
Chubb
$3.881.40%N/A17.12%31 Years
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$0.840.34%N/A12.57%N/A

Latest ALB, WST, and CB Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/23/2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
quarterly$0.220.39%11/12/202511/12/202511/19/2025
8/14/2025
Chubb Limited stock logo
CB
Chubb
quarterly$0.971.41%9/12/20259/12/202510/3/2025
7/22/2025
Albemarle Corporation stock logo
ALB
Albemarle
quarterly$0.40501.94%9/12/20259/12/202510/1/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Albemarle Corporation stock logo
ALB
Albemarle
0.38
2.31
1.47
Chubb Limited stock logo
CB
Chubb
0.18
0.28
0.28
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.07
2.78
2.08

Institutional Ownership

CompanyInstitutional Ownership
Albemarle Corporation stock logo
ALB
Albemarle
92.87%
Chubb Limited stock logo
CB
Chubb
83.81%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
93.90%

Insider Ownership

CompanyInsider Ownership
Albemarle Corporation stock logo
ALB
Albemarle
0.33%
Chubb Limited stock logo
CB
Chubb
0.86%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.57%
CompanyEmployeesShares OutstandingFree FloatOptionable
Albemarle Corporation stock logo
ALB
Albemarle
8,300117.68 million117.30 millionOptionable
Chubb Limited stock logo
CB
Chubb
43,000398.69 million395.26 millionOptionable
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
10,60071.91 million71.50 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Albemarle stock logo

Albemarle NYSE:ALB

$79.62 -5.30 (-6.25%)
Closing price 03:59 PM Eastern
Extended Trading
$79.88 +0.26 (+0.33%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Specialties segment provides bromine-based specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; develops and manufactures cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators. The Ketjen segment offers clean fuels technologies (CFT), which is composed of hydroprocessing catalysts (HPC) together with isomerization and akylation catalysts; fluidized catalytic cracking (FCC) catalysts and additives; and performance catalyst solutions (PCS), which is composed of organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.

Chubb stock logo

Chubb NYSE:CB

$276.52 +1.45 (+0.53%)
Closing price 03:59 PM Eastern
Extended Trading
$277.26 +0.74 (+0.27%)
As of 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Chubb Limited provides insurance and reinsurance products worldwide. The company's North America Commercial P&C Insurance segment offers commercial property, casualty, workers' compensation, package policies, risk management, financial lines, marine, construction, environmental, medical risk, cyber risk, surety, and casualty; and group accident and health insurance to large, middle market, and small commercial businesses. Its North America Personal P&C Insurance segment provides affluent and high net worth individuals and families with homeowners, automobile and collector cars, valuable articles, personal and excess liability, travel insurance, and recreational marine insurance and services. The company's North America Agricultural Insurance segment offers multiple peril crop and crop-hail insurance; and coverage for farm, ranch, and specialty property and casualty, and commercial agriculture products. Its Overseas General Insurance segment provides coverage for traditional commercial property and casualty; specialty categories, such as financial lines, marine, energy, aviation, political risk, and construction; and group accident and health, and traditional and specialty personal lines for corporations, middle markets, and small customers through retail brokers, agents, and other channels. The company's Global Reinsurance segment offers traditional and specialty reinsurance under the Chubb Tempest Re brand to property and casualty companies. Its Life Insurance segment provides protection and savings products comprising whole life, endowment plans, individual and life, group term life, health protection, personal accident, credit life, universal life, group employee benefits, and unit linked contracts. It markets its products primarily through insurance and reinsurance brokers. The company was formerly known as ACE Limited and changed its name to Chubb Limited in January 2016. Chubb Limited was incorporated in 1985 and is headquartered in Zurich, Switzerland.

West Pharmaceutical Services stock logo

West Pharmaceutical Services NYSE:WST

$243.75 -3.20 (-1.29%)
Closing price 03:59 PM Eastern
Extended Trading
$243.74 -0.01 (0.00%)
As of 06:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.